[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.
Read more Oncodesign is a technical and scientific company whose raison d’être is the innovation that makes it stand out. Our innovation stems intrinsically from our vision, from the way that each individual looks at things. Technological innovation is based on a set of knowledge and technologies which, in combination, answer a new question and create efficiency and therefore growth for customers and partners.
AI is the key technology that will ultimately support our innovation
The Drug Discovery process is how Oncodesign stands out in the preclinical services market
The development of our clinical drug candidates, particularly in oncology, is our ultimate purpose
Oncodesign addresses an ever-growing need for innovation in the healthcare industry. Oncodesign identifies new pathways, establishes strategic connections for therapeutic innovation, and guides its own developments and those of its customers in a patient-centered approach.
Technological innovation is at the heart of the Oncodesign model: the strategic Study, Discovery and Experimentation activities, designed and carried out by Oncodesign, contribute to a better approach to congenital and acquired treatment resistance, to more effective treatments, and to the reduction of treatment failure:
This unique innovation model makes Oncodesign a biopharmaceutical company capable of generating knowledge about patients and their diseases and choosing effective therapeutic solutions, in order to guide its research and that of its customers right from the start by offering services, partnerships and licensing.
For Oncodesign, there is no such thing as a good or bad molecule, since all have their own potential, properties and targets which determine how they are used – there are only molecules whose application must be found.